Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND.
Christopher Michael Tully
No relevant relationships to disclose
Bernard H. Bochner
No relevant relationships to disclose
Guido Dalbagni
No relevant relationships to disclose
Emily C. Zabor
No relevant relationships to disclose
Harry W. Herr
No relevant relationships to disclose
S. Machele Donat
No relevant relationships to disclose
Irina Ostrovnaya
No relevant relationships to disclose
Ashley Marie Regazzi
No relevant relationships to disclose
Philip H. Kim
No relevant relationships to disclose
John P. Sfakianos
No relevant relationships to disclose
Jonathan E. Rosenberg
No relevant relationships to disclose
Dean F. Bajorin
Consultant or Advisory Role - Bristol-Myers Squibb; Lilly
Honoraria - Lilly